Head to head
P21 against Cerebrolysin
A synthetic fragment designed from a neurotrophic factor against a brain-derived peptide mixture used clinically in many countries. One has animal data only; the other has decades of trials with a contested quality record.
Column A
P21P21 (P021, CNTF-derived peptide)
A small peptide derived from a neurotrophic factor studied for promoting new neuron growth and protecting against Alzheimer-like changes in animals.
Column B
CerebrolysinCerebrolysin (porcine brain-derived neuropeptides)
A standardized mixture of neuropeptides used clinically in many countries for stroke, dementia, and TBI.
Side by side, on the facts we can check
| Attribute | P21 | Cerebrolysin |
|---|---|---|
| Category | Nootropic & CNS | Nootropic & CNS |
| FDA status | Not FDA-approved; experimental | Not FDA-approved (approved in 30+ countries) |
| Half-life | Short | Varies by fraction |
| Molecular weight | ~650 Da | Mixture (<10 kDa peptides) |
| Mechanism | Mimics ciliary neurotrophic factor signaling to promote new neuron formation and synaptic plasticity in the hippocampus. | Its neuropeptide fractions mimic neurotrophic factors such as BDNF and NGF and activate neuroprotective signaling pathways in the brain. |
| Human studies cited | 0 | 1 |
| Legal status, US | Not approved; research use only | Not approved |
Frequently asked questions
What is the difference between P21 and Cerebrolysin?
P21: A small peptide derived from a neurotrophic factor studied for promoting new neuron growth and protecting against Alzheimer-like changes in animals. Cerebrolysin: A standardized mixture of neuropeptides used clinically in many countries for stroke, dementia, and TBI.
Which has stronger research evidence, P21 or Cerebrolysin?
This database does not grade compounds. It counts what was run in people: 0 of the 3 studies cited on the P21 profile were human work, against 1 of 3 for Cerebrolysin. Those counts are of our own citation lists and understate any larger literature, and neither is a recommendation.
Are P21 and Cerebrolysin FDA-approved?
P21: Not FDA-approved; experimental. Cerebrolysin: Not FDA-approved (approved in 30+ countries).
Reviewed Sep 2026. This page sets two published records side by side. It is educational, it is not medical advice, and it contains no dosing protocols or recommendations for personal use.